Beth Hecht
Chief Legal Officer and Corporate Secretary · 4 filings · Latest: May 1, 2026
Xeris Biopharma Holdings, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XERS | Beth Hecht | Chief Legal Officer and Corporate Secretary | May 1, 2026 | Sale | $6.23 | 16,667 | $103.8K | 1,193,173 | |
XERS | Beth Hecht | Chief Legal Officer and Corporate Secretary | Apr 1, 2026 | Sale | $5.99 | 16,667 | $99.9K | 1,209,840 | |
XERS | Beth Hecht | Chief Legal Officer and Corporate Secretary | Mar 2, 2026 | Sale | $6.25 | 16,667 | $104.1K | 1,226,507 | |
XERS | BETH HECHT | — | Mar 2, 2026 | Proposed Sale | $6.12 | 66,668 | $408.0K | — | |
XERS | Beth Hecht | Chief Legal Officer and Corporate Secretary | Feb 2, 2026 | Sale | $7.45 | 16,667 | $124.1K | 1,243,174 | |
XERS | BETH HECHT | — | Nov 11, 2025 | Proposed Sale | $7.72 | 66,668 | $514.7K | — | |
XERS | Hecht Beth | — | Mar 20, 2025 | Proposed Sale | $5.14 | 40,000 | $205.6K | — |